Combination of CTLA-4 and TGFβ1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak

Clinical Immunology

Volumn 131, Issue 3, 2009, Pages 404-409

  Chen, Rong Fu ^a   Wang, Lin ^a   Cheng, Jiin Tsuey ^b   Chuang, Hau ^a   Chang, Jen Chieh ^a   Liu, Jien Wei ^c   Lin, I Chun ^a   Yang, Kuender D ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

CTLA 4; DHF; Polymorphisms; TGF 1; Virus load

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ARTICLE; BLOOD; CONTROLLED STUDY; CORRELATION ANALYSIS; CTLA 4 GENE; DENGUE; DISEASE SEVERITY; EPIDEMIC; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; TAIWAN; TGFBETA1 GENE; VIRUS LOAD;

ALLELES; ANTIGENS, CD; DENGUE HEMORRHAGIC FEVER; DISEASE OUTBREAKS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; VIRAL LOAD;

EID: 67349196789     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.01.015     Document Type: Article

References (26)

1. Gubler D.J. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp. 277 (2006) 3-16
2. Malavige G.N., Fernando S., Fernando D.J., and Seneviratne S.L. Dengue viral infections. Postgrad. Med. J. 80 (2004) 588-601
3. Chaturvedi U.C., Agarwal R., Elbishbishi E.A., and Mustafa A.S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol. Med. Microbiol. 28 (2000) 183-188
4. Lühn K., Simmons C.P., Moran E., Dung N.T., Chau T.N., Quyen N.T., Thao le T.T., Van Ngoc T., Dung N.M., Wills B., Farrar J., McMichael A.J., Dong T., and Rowland-Jones S. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J. Exp. Med. 204 (2007) 979-985
5. Chaturvedi U.C., Shrivastava R., Tripathi R.K., and Nagar R. Dengue virus-specific suppressor T cells: current perspectives. FEMS Immunol. Med. Microbiol. 50 (2007) 285-299
6. Agarwal R., Elbishbishi E.A., Chaturvedi U.C., Nagar R., and Mustafa A.S. Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. Int. J. Exp. Pathol. 80 (1999) 143-149
7. Grainger D.J., Heathcote K., Chiano M.K., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., and Spector T.D. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8 (1999) 93-97
8. Kimura T., Saito T., Yoshimura M., Yixuan S., Baba M., Ji G., Muramatsu M., and Kawata S. Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J. Infect. Dis. 193 (2006) 1371-1374
9. Cecchinato V., Tryniszewska E., Ma Z.M., Vaccari M., Boasso A., Tsai W.P., Petrovas C., Fuchs D., Heraud J.M., Venzon D., Shearer G.M., Koup R.A., Lowy I., Miller C.J., and Franchini G. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J. Immunol. 180 (2008) 5439-5447
10. Jiang Z., Feng X., Zhang W., Gao F., Ling Q., Zhou L., Xie H., Chen Q., and Zheng S. Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Liver Int. 27 (2007) 1202-1208
11. Chen R.F., Yang K.D., Wang L., Liu J.W., Chiu C.C., and Cheng J.T. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 1106-1113
12. Wang L., Chen R.F., Liu J.W., Yu H.R., Kuo H.C., and Yang K.D. Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am. J. Trop. Med. Hyg. 77 (2007) 297-302
13. Yeh W.T., Chen R.F., Wang L., Liu J.W., Shaio M.F., and Yang K.D. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 48 (2006) 84-90
14. World Health Organization. Dengue Hemorrhage Fever: Diagnosis, Treatment, Prevention and Control (1997), World Health Organization, Geneva
15. Chang J.C., Liu C.A., Chuang H., Ou C.Y., Hsu T.Y., Huang E.Y., and Yang K.D. Gender-limited association of cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism with cord blood IgE levels. Pediatr. Allergy Immunol. 15 (2004) 1-7
16. Chen R.F., Liu J.W., Yeh W.T., Wang L., Chang J.C., Yu H.R., Cheng J.T., and Yang K.D. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 44 (2005) 43-50
17. Chen R.F., Yeh W.T., Yang M.Y., and Yang K.D. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol. Med. Microbiol. 30 (2001) 1-7
18. Su T.H., Chang T.Y., Lee Y.J., Chen C.K., Liu H.F., Chu C.C., Lin M., Wang P.T., Huang W.C., Chen T.C., and Yang Y.C. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28 (2007) 1237-1240
19. Mak J.C., Leung H.C., Sham A.S., Mok T.Y., Poon Y.N., Ling S.O., Wong K.C., and Chan-Yeung M. Genetic polymorphisms and plasma levels of transforming growth factor-beta(1) in Chinese patients with tuberculosis in Hong Kong. Cytokine 40 (2007) 177-182
20. Botto L.D., and Khoury M.J. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am. J. Epidemiol. 153 (2001) 1016-1020
21. Yang K.D., Ou C.Y., Hsu T.Y., Chang J.C., Chuang H., Liu C.A., Liang H.M., Kuo H.C., Chen R.F., and Huang E.Y. Interaction of maternal atopy, CTLA-4 gene polymorphism and gender on antenatal immunoglobulin E production. Clin. Exp. Allergy 37 (2007) 680-687
22. Sugiura Y., Niimi T., Sato S., Yoshinouchi T., Banno S., Naniwa T., Maeda H., Shimizu S., and Ueda R. Transforming growth factor beta 1 gene polymorphism in rheumatoid arthritis. Ann. Rheum. Dis. 61 (2002) 826-828
23. Kimura T., Saito T., Yoshimura M., Yixuan S., Baba M., Ji G., Muramatsu M., and Kawata S. Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J. Infect. Dis. 193 (2006) 1371-1374
24. Yim H.E., Bae I.S., Yoo K.H., Hong Y.S., and Lee J.W. Genetic control of VEGF and TGF-beta1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux. Pediatr. Res. 62 (2007) 183-187
25. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D.W., Nisalak A., Ennis F.A., and Rothman A.L. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185 (2002) 1213-1221
26. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2-9